1. Home
  2. BIVI vs GWAV Comparison

BIVI vs GWAV Comparison

Compare BIVI & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • GWAV
  • Stock Information
  • Founded
  • BIVI 2013
  • GWAV 2002
  • Country
  • BIVI United States
  • GWAV United States
  • Employees
  • BIVI N/A
  • GWAV N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • GWAV Packaged Foods
  • Sector
  • BIVI Health Care
  • GWAV Consumer Staples
  • Exchange
  • BIVI Nasdaq
  • GWAV Nasdaq
  • Market Cap
  • BIVI 11.9M
  • GWAV 12.8M
  • IPO Year
  • BIVI N/A
  • GWAV N/A
  • Fundamental
  • Price
  • BIVI $1.82
  • GWAV $6.57
  • Analyst Decision
  • BIVI
  • GWAV
  • Analyst Count
  • BIVI 0
  • GWAV 0
  • Target Price
  • BIVI N/A
  • GWAV N/A
  • AVG Volume (30 Days)
  • BIVI 323.5K
  • GWAV 90.8K
  • Earning Date
  • BIVI 11-12-2025
  • GWAV 11-14-2025
  • Dividend Yield
  • BIVI N/A
  • GWAV N/A
  • EPS Growth
  • BIVI N/A
  • GWAV N/A
  • EPS
  • BIVI N/A
  • GWAV N/A
  • Revenue
  • BIVI N/A
  • GWAV $33,315,859.00
  • Revenue This Year
  • BIVI N/A
  • GWAV N/A
  • Revenue Next Year
  • BIVI N/A
  • GWAV N/A
  • P/E Ratio
  • BIVI N/A
  • GWAV N/A
  • Revenue Growth
  • BIVI N/A
  • GWAV N/A
  • 52 Week Low
  • BIVI $1.42
  • GWAV $6.02
  • 52 Week High
  • BIVI $75.00
  • GWAV $119.90
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 33.82
  • GWAV 27.46
  • Support Level
  • BIVI $1.54
  • GWAV $6.02
  • Resistance Level
  • BIVI $2.03
  • GWAV $7.72
  • Average True Range (ATR)
  • BIVI 0.15
  • GWAV 0.63
  • MACD
  • BIVI 0.23
  • GWAV 0.44
  • Stochastic Oscillator
  • BIVI 65.57
  • GWAV 24.23

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.

Share on Social Networks: